Proteomics

Dataset Information

0

Delayed induction of type I and III interferons enhances nasal epithelial permissiveness to SARS-CoV-2


ABSTRACT: We provide the first comprehensive analysis of nasal cell responses to SARS-COV-2 using single cell transcriptomics and proteomics. The immune response to SARS-CoV-2 is dominated by a delayed type I and III IFN response, which is too slow to contain viral replication. Cells transitioning from secretory to ciliated states are highly permissive to SARS-CoV-2, whereas goblet cells are relatively resistant. Cell-type differences in the production and response to IFN-I/III correlate with permissiveness. Pre-treatment with recombinant IFNs potently restricts SARS-CoV-2. Nasal delivery of recombinant IFNs is a promising prophylactic strategy for SARS-CoV-2

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human) Severe Acute Respiratory Syndrome Coronavirus 2

TISSUE(S): Primary Cell, Epithelial Cell

SUBMITTER: Matthias Trost  

LAB HEAD: Matthias Trost

PROVIDER: PXD022523 | Pride | 2021-05-25

REPOSITORIES: Pride

altmetric image

Publications


The nasal epithelium is a plausible entry point for SARS-CoV-2, a site of pathogenesis and transmission, and may initiate the host response to SARS-CoV-2. Antiviral interferon (IFN) responses are critical to outcome of SARS-CoV-2. Yet little is known about the interaction between SARS-CoV-2 and innate immunity in this tissue. Here we apply single-cell RNA sequencing and proteomics to a primary cell model of human nasal epithelium differentiated at air-liquid interface. SARS-CoV-2 demonstrates wi  ...[more]

Similar Datasets

2021-09-15 | PXD022904 | Pride
2022-06-03 | E-MTAB-11261 | biostudies-arrayexpress
2022-08-11 | PXD034045 | Pride
2011-08-31 | E-GEOD-23955 | biostudies-arrayexpress
2021-06-19 | E-MTAB-10128 | biostudies-arrayexpress
2013-05-28 | E-GEOD-11704 | biostudies-arrayexpress
2014-10-31 | E-GEOD-52920 | biostudies-arrayexpress
2014-05-22 | E-GEOD-50855 | biostudies-arrayexpress
2022-06-01 | E-MTAB-11237 | biostudies-arrayexpress
2022-06-01 | E-MTAB-11232 | biostudies-arrayexpress